The World Health Organization (WHO) has reaffirmed that the mpox outbreak remains a Public Health Emergency of International Concern (PHEIC). This decision, initially declared in August 2024, is driven by a surge in cases and the spread of a new variant, clade Ib, primarily impacting the Democratic Republic of Congo (DRC), Uganda, and Burundi.

Since early 2024, over 21,000 laboratory-confirmed mpox cases have been reported globally, resulting in 70 fatalities, with the majority occurring in the DRC. The outbreak has also led to more than 50,000 suspected cases and over 1,000 deaths in the previous year.

The WHO’s emergency status aims to enhance surveillance, resource allocation, and international collaboration to combat the outbreak. However, efforts are hindered by ongoing violence in eastern DRC, complicating response initiatives.

Mpox, a viral infection transmitted through close contact, manifests with flu-like symptoms and characteristic lesions. While typically mild, it can be fatal, especially in regions with limited healthcare infrastructure. The emergence of clade Ib has raised concerns due to its rapid spread and impact on children in affected areas.

The international community is urged to intensify support for affected countries, focusing on vaccination campaigns, public health education, and strengthening healthcare systems to manage and contain the outbreak effectively.